Summary:
This is a 12 week study to determine the efficacy and safety of an investigational medication to treat patients with moderate to severe chronic low back pain.
Determine if you are eligible for this clinical trial.
Qualified Participants Must:
• Be over 18 years of age
•
Have a documented diagnosis of moderate to severe chronic low back pain
•
Require daily use of amalgesic
Qualified Participants May Receive:
Compensation for time and travel.